Lisata Therapeutics, Inc. Profile Avatar - Palmy Investing

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient …

Biotechnology
US, Basking Ridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of LSTA's Analysis
CIK: - CUSIP: 128058302 ISIN: US1280583022 LEI: - UEI: -
Secondary Listings
LSTA has no secondary listings inside our databases.